<- Go Home

Retractable Technologies, Inc.

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Market Cap

$21.7M

Volume

74.6K

Cash and Equivalents

$2.6M

EBITDA

-$12.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$47.0K

Profit Margin

0.12%

52 Week High

$1.14

52 Week Low

$0.60

Dividend

N/A

Price / Book Value

0.29

Price / Earnings

-1.68

Price / Tangible Book Value

0.29

Enterprise Value

-$13.9M

Enterprise Value / EBITDA

1.11

Operating Income

-$20.2M

Return on Equity

15.56%

Return on Assets

-8.33

Cash and Short Term Investments

$37.0M

Debt

$1.2M

Equity

$74.4M

Revenue

$38.3M

Unlevered FCF

-$2.1M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches